The Scottish Medicines Consortium, (SMC), has announced it will fund the drug Tucatinib to treat women with breast cancer who had failed to respond to other medications and had seen theircancer return. We hope and expect that the drug will now be approved by the National Institute for Health and Care Excellence, (NICE) across the…
Details
Cancer patients must have their seasonal flu jab to ensure them against further critical illness. Cancer patients will be immunocompromised due to their cancer and ongoing treatment. They are therefore at increased risk of complications like pneumonia or hospitalization from Flu and COVID-19. Last year there were fewer flu cases than normal because of social…
Details
Every year many thousands of women across the world will be diagnosed with Cervical Cancer. And nearly a third of women diagnosed will die from this disease. In emerging areas of Africa and Asia where cervical tests are unavailable, a Cervical Cancer diagnosis is effectively a death sentence. Screenings through relevant country early detection programmes for…
DetailsWe are indebted to the American Institute for Cancer Research for their report on the influence on the Covid pandemic’s influence on Cancer increase. COVID-19 has been a big part of conversations about health and health care throughout 2021. And unfortunately, sometimes a focus on steps that are promoted as offering protection against this very real…
Details